# Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients

> **NCT03200184** · PHASE4 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 1448 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** sofosbuvir and daclatasvir

## Key facts

- **NCT ID:** NCT03200184
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 1448 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03200184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03200184, "Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03200184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*